Nivolumab

Explore clinical trials studying Nivolumab. Study availability and eligibility vary by location and protocol.

6 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Nivolumab trial results

Not yet recruiting

NCT05835804

Enrolling by invitation

NCT06931613

Conditions: Autologous Haemopoietic Stem Cell Transplant, Children, Disease Attributes, +14 more
Locations: N. N. Blokhin Russian Cancer Research Center, Moscow, Russia Moscow, Russia

Pavlov University, RM Gorbacheva Research Institute Saint Petersburg, Russia

Enrolling by invitation

NCT06871007

Conditions: Children, Nivolumab, Primary Mediastinal (Thymic) Large B-Cell Lymphoma
Locations: Dmitry Rogachev National Research Center Moscow, Russia

Pavlov University, RM Gorbacheva Research Institute Saint Petersburg, Russia

Active, not recruiting

NCT04572451

Conditions: Antineoplastic Agents, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, +15 more
Locations: University of Chicago Medical Center Chicago, Illinois, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

Completed

NCT02933346

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: CH du Pays d'Aix Aix-en-Provence, France

Clinique du Rambot Aix-en-Provence, France

CHU d'Amiens-Picardie Amiens, France

CHU d'Angers Angers, France

View all 72 locations

Suspended

NCT07011550

Conditions: Bevacizumab, Microsatellite-stable Colorectal Cancer, Nivolumab, +1 more
Locations: MD Anderson Cancer Center Houston, Texas, United States